Interleukin 3D structures
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
**[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | ||
**[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | **[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | ||
| - | **[[4g6j]], [[4g6m]], [[5bvp]] - hIL-1 β + antibody<br /> | + | **[[4g6j]], [[4g6m]], [[5bvp]], [[7chy]], [[7chz]] - hIL-1 β + antibody<br /> |
**[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | **[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | ||
**[[1md6]] – mIL-1F5 – mouse<BR /> | **[[1md6]] – mIL-1F5 – mouse<BR /> | ||
| Line 31: | Line 31: | ||
**[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | **[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | ||
| - | **[[3qb1]] - hIL-2 (mutant)<br /> | + | **[[3qb1]], [[7m2g]] - hIL-2 (mutant)<br /> |
**[[1irl]] – hIL-2 (mutant) - NMR<BR /> | **[[1irl]] – hIL-2 (mutant) - NMR<BR /> | ||
**[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | **[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | ||
| Line 40: | Line 40: | ||
**[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | **[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | ||
**[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | **[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | ||
| - | **[[5lqb]] - hIL-2 + antibody<br /> | + | **[[5lqb]], [[6ye3]], [[7dr4]] - hIL-2 + antibody<br /> |
**[[4yue]] - mIL-2 + antibody<br /> | **[[4yue]] - mIL-2 + antibody<br /> | ||
**[[4yqx]] - IL-2 + antibody - rat<br /> | **[[4yqx]] - IL-2 + antibody - rat<br /> | ||
| Line 74: | Line 74: | ||
*IL-6 | *IL-6 | ||
| - | **[[1alu]] – hIL-6<BR /> | + | **[[1alu]], [[7nxz]] – hIL-6<BR /> |
**[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | **[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | ||
**[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | **[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | ||
| Line 95: | Line 95: | ||
**[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | **[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | ||
**[[3il8]], [[5d14]], [[4xdx]] – hIL-8 residues 28-99<BR /> | **[[3il8]], [[5d14]], [[4xdx]] – hIL-8 residues 28-99<BR /> | ||
| + | **[[6xmn]] – hIL-8 residues 28-93 + CXCR1 N-terminal - NMR<BR /> | ||
**[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | **[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | ||
| - | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | + | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide<br /> |
| + | **[[6wzm]] – hIL-8 + antibody<BR /> | ||
*IL-10 | *IL-10 | ||
| Line 124: | Line 126: | ||
**[[5mj3]], [[5mj4]], [[5njd]] - hIL-12 β + hIL-23 α + antibody<br /> | **[[5mj3]], [[5mj4]], [[5njd]] - hIL-12 β + hIL-23 α + antibody<br /> | ||
**[[5mzv]] - hIL-12 β + hIL-23 α + hIL-23 receptor + antibody<br /> | **[[5mzv]] - hIL-12 β + hIL-23 α + hIL-23 receptor + antibody<br /> | ||
| + | **[[6wdq]] - hIL-12 β + hIL-23 α + hIL-12 receptor + hIL-23 receptor <br /> | ||
**[[5mxa]] - hIL-12 β + hIL- 23 α<br /> | **[[5mxa]] - hIL-12 β + hIL- 23 α<br /> | ||
**[[5mj3]], [[5mj4]] - hIL-12 β + hIL-23 α + alphabody MB3<br /> | **[[5mj3]], [[5mj4]] - hIL-12 β + hIL-23 α + alphabody MB3<br /> | ||
**[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> | ||
**[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | **[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | ||
| - | **[[6sff]] - mIL-12 β <br /> | + | **[[6sff]], [[6smc]], [[6sp3]] - mIL-12 β <br /> |
*IL-13 | *IL-13 | ||
| Line 156: | Line 159: | ||
**[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | **[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | ||
**[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | **[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | ||
| - | **[[2vxs]], [[4qhu]] - hIL-17A + antibody<BR /> | + | **[[2vxs]], [[4qhu]], [[6wio]], [[6wir]] - hIL-17A + antibody<BR /> |
**[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | **[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | ||
**[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | **[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | ||
| Line 194: | Line 197: | ||
**[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | **[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | ||
**[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody<br /> | **[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody<br /> | ||
| + | **[[6weo]] - hIL-22 + IL-22 receptor + IL-10 receptor <br /> | ||
**[[4o6k]] – IL-22 – zebra fish<BR /> | **[[4o6k]] – IL-22 – zebra fish<BR /> | ||
| Line 220: | Line 224: | ||
**[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | **[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | ||
| + | **[[4kc3]] - hIL-33 + IL—1 receptor-like 1<br /> | ||
| + | **[[5iv4]] - mIL-33 + IL—1 receptor-like 1 + IL-1 receptor accessory protein<br /> | ||
*IL-34 | *IL-34 | ||
Revision as of 07:32, 6 October 2021
3D structures of interleukin
Updated on 06-October-2021
